The Chemours Company (CC) Stock Forecast: What Could Drive It in 2026
Short answer
What is actually driving The Chemours Company (CC) right now is Opteon refrigerant growth: The Thermal & Specialized Solutions segment, anchored by Opteon low-GWP refrigerants, is Chemours' clearest growth engine. Revenue (FY2025) is ~$5.8B. If that keeps playing out, the setup is favourable; the risk to it is pFAS environmental litigation and remediation are the defining risk: Chemours faces thousands of personal injury claims in the AFFF multi-district litigation with bellwether trials that could produce unpredictable damages, on top of the $450 million EPA and DOJ settlement already reached in 2026. No one can predict where CC trades, and Walnut does not publish targets, so treat this as a scenario, not a price target or prediction.
What could drive The Chemours Company (CC) higher?
1. Opteon refrigerant growth
The Thermal & Specialized Solutions segment, anchored by Opteon low-GWP refrigerants, is Chemours' clearest growth engine. Regulatory HFC phase-downs under the AIM Act and similar rules abroad are shifting demand toward the newer chemistries Chemours produces. Management has pointed to this franchise as the main driver behind its 2026 guidance for net sales growth of roughly 3 to 5 percent.
2. TiO2 pigment cyclical recovery
Titanium Technologies is the largest revenue segment and is highly sensitive to construction, coatings, and industrial demand. Pricing and volumes have been pressured through the recent cycle, so any recovery in global coatings demand or pigment pricing would be a meaningful earnings lever. The flip side is that continued weakness keeps consolidated margins subdued.
3. Cost, cash flow, and dividend
Chemours has emphasized cost discipline, capital-expenditure control (guided to roughly $275 to $325 million in 2026), and free cash flow conversion above 20 percent. The company pays a modest dividend of about $0.35 per share annually. Delivering on its $800 to $900 million adjusted EBITDA guidance would support the balance sheet and its litigation obligations.
4. PFAS liability resolution
Progress on resolving PFAS exposure is itself a potential catalyst. The June 2026 EPA and DOJ settlement of about $450 million removed some uncertainty at legacy sites. Further settlements or favorable outcomes in the remaining AFFF litigation could reduce the discount the market applies, though the timing and size of remaining liabilities are uncertain.
What could weigh on CC?
PFAS environmental litigation and remediation are the defining risk: Chemours faces thousands of personal injury claims in the AFFF multi-district litigation with bellwether trials that could produce unpredictable damages, on top of the $450 million EPA and DOJ settlement already reached in 2026. The Titanium Technologies segment is cyclical and exposed to weak construction and coatings demand plus low-cost pigment competition. The company posted a net loss in Q1 2026, underscoring thin profitability. Leverage and the cash demands of legal settlements constrain financial flexibility. Regulatory, raw-material, and currency swings add further volatility to results.
Where CC trades today
A forecast starts from where the stock actually is. These are CC's current figures, not a projection: the drivers and risks above are what would move them.
Snapshot for CC as of July 2026, sourced from Yahoo Finance and may be delayed. Valuation figures move with price and earnings; verify the current numbers with your broker before deciding.
How to think about a CC forecast
Rather than chasing a price target, it tends to help to weigh the drivers above against the risks, decide how long you are willing to hold, and size the position so a wrong call is survivable. A “forecast” is really a probability-weighted view of those drivers playing out, not a number.
For the full picture, see the CC guide and whether CC is a buy. In Walnut you can pressure-test the thesis against your real portfolio.
The bottom line on the CC outlook
The bottom line: what is driving The Chemours Company (CC) is Opteon refrigerant growth, with revenue (fy2025) at ~$5.8B. If that keeps playing out the setup is favourable; the risk is pFAS environmental litigation and remediation are the defining risk: Chemours faces thousands of personal injury claims in the AFFF multi-district litigation with bellwether trials that could produce unpredictable damages, on top of the $450 million EPA and DOJ settlement already reached in 2026. No one can predict the price, so treat any CC forecast as a scenario, not a target or prediction, and decide from your own thesis and time horizon. Walnut is not an investment adviser.
Build a basket around CC with Walnut
Use The Chemours Company as one constituent in a thematic basket Walnut's AI helps you assemble. Describe a thesis you believe in, the AI proposes the holdings and weights, and you approve before any broker order.
FAQ
What is the forecast for The Chemours Company (CC)?
+
No one can reliably predict where CC will trade, and Walnut does not publish price targets. What is more useful is the setup: the drivers that could push The Chemours Company higher and the risks that could weigh on it. This page lays out both so you can form your own view. Not a recommendation.
What could drive CC higher?
+
The main growth drivers are Opteon refrigerant growth; TiO2 pigment cyclical recovery; Cost, cash flow, and dividend. Whether they play out is the real question, not a guaranteed path.
What are the risks to CC?
+
PFAS environmental litigation and remediation are the defining risk: Chemours faces thousands of personal injury claims in the AFFF multi-district litigation with bellwether trials that could produce unpredictable damages, on top of the $450 million EPA and DOJ settlement already reached in 2026. The Titanium Technologies segment is cyclical and exposed to weak construction and coatings demand plus low-cost pigment competition. The company posted a net loss in Q1 2026, underscoring thin profitability. Leverage and the cash demands of legal settlements constrain financial flexibility. Regulatory, raw-material, and currency swings add further volatility to results.
Will CC stock go up in 2026?
+
Nobody knows, and anyone who says they do is guessing. The Chemours Company's direction depends on whether the drivers above outweigh the risks, plus the broader market. Focus on the thesis and your time horizon rather than a single-year call.
Is CC a buy?
+
That depends on your thesis, time horizon, and what you already own, not on a forecast. See the CC "is it a buy?" page for a framework. Walnut is not an investment adviser.
What is the growth driver for Chemours?
+
The clearest growth driver is the Opteon low-GWP refrigerant line, which benefits from regulatory phase-downs of higher-emission HFCs under the AIM Act and comparable rules internationally. This higher-margin franchise is the main support behind management's 2026 sales-growth guidance.
Walnut is informational, not investment advice. This page describes drivers and risks; it is not a price forecast, target, or recommendation. Markets are uncertain and past performance does not predict future results.